Moderna shares fall after judge sides with Arbutus in patent fight
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that strengthened Arbutus' arguments in a patent infringement lawsuit ...
Source: saltwire.com
Page 2 - Genevant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genevant Sciences Today - Breaking & Trending Today
Moderna shares fall after judge sides with Arbutus in patent fight
Roivant's shares gained 4% in afternoon trading, while its subsidiary Arbutus rose more than 17%. In a so-called "claim construction order", U.S. District Judge Mitchell Goldberg interpreted parts of the patents in ways that strengthened Arbutus' case, rejecting Moderna's proposed definitions. The order is relevant in determining whether Moderna's vaccines are covered by Arbutus' patented technology.
Source: yahoo.com
Global Lipid Nanoparticle Manufacturing Market Projects
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Five stories that made 2023 a momentous year for life sciences IP
The dawn of a new era for CRISPR patent strategy, multiplying mRNA patent wars, and 10x Genomics and NanoString’s cross-border spat were among the developments that defined the last 12 months
Source: iam-media.com
Global Lipid Nanoparticles Industry demand is estimated to sustain a 14.2% CAGR from 2023 to 2033 ba
Lipid Nanoparticles IndustryIt is projected that the global lipid nanoparticles industry demand will be valued at US$ 877.8 million in 2023. The market is expected to expand at a CAGR of 14.2% between 2023 and 2033, reaching approximately US$ 3.3 billion by 2033, due to rising health concerns about dietary supplemen...
Source: pharmiweb.com